NO20005890D0 - Antiangiogene peptidmedikamenter - Google Patents

Antiangiogene peptidmedikamenter

Info

Publication number
NO20005890D0
NO20005890D0 NO20005890A NO20005890A NO20005890D0 NO 20005890 D0 NO20005890 D0 NO 20005890D0 NO 20005890 A NO20005890 A NO 20005890A NO 20005890 A NO20005890 A NO 20005890A NO 20005890 D0 NO20005890 D0 NO 20005890D0
Authority
NO
Norway
Prior art keywords
peptide drugs
antiangiogenic peptide
antiangiogenic
drugs
peptide
Prior art date
Application number
NO20005890A
Other languages
English (en)
Other versions
NO326871B1 (no
NO20005890L (no
Inventor
Jack Henkin
Fortuna Haviv
Michael F Bradley
Douglas M Kalvin
Andrew J Schneider
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20005890D0 publication Critical patent/NO20005890D0/no
Publication of NO20005890L publication Critical patent/NO20005890L/no
Publication of NO326871B1 publication Critical patent/NO326871B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
NO20005890A 1998-05-22 2000-11-21 Nye peptidforbindelser med antiangiogene egenskaper, sammensetninger og medikamenter inneholdende disse. NO326871B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8374598A 1998-05-22 1998-05-22
US25057499A 1999-02-16 1999-02-16
US27746699A 1999-03-26 1999-03-26
PCT/US1999/011448 WO1999061476A1 (en) 1998-05-22 1999-05-21 Peptide antiangiogenic drugs

Publications (3)

Publication Number Publication Date
NO20005890D0 true NO20005890D0 (no) 2000-11-21
NO20005890L NO20005890L (no) 2001-01-12
NO326871B1 NO326871B1 (no) 2009-03-09

Family

ID=27374598

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005890A NO326871B1 (no) 1998-05-22 2000-11-21 Nye peptidforbindelser med antiangiogene egenskaper, sammensetninger og medikamenter inneholdende disse.

Country Status (25)

Country Link
EP (1) EP1078002B1 (no)
JP (3) JP3753612B2 (no)
KR (1) KR100447696B1 (no)
CN (1) CN1311796A (no)
AR (1) AR018371A1 (no)
AT (1) ATE396204T1 (no)
AU (1) AU764277B2 (no)
BG (1) BG65065B1 (no)
BR (1) BR9910639A (no)
CA (1) CA2329250C (no)
CO (1) CO5080726A1 (no)
CY (1) CY1109118T1 (no)
CZ (1) CZ299639B6 (no)
DE (1) DE69938782D1 (no)
ES (1) ES2307337T3 (no)
HU (1) HUP0102579A3 (no)
NO (1) NO326871B1 (no)
NZ (1) NZ507912A (no)
PL (1) PL200471B1 (no)
PT (1) PT1078002E (no)
SI (1) SI1078002T1 (no)
SK (1) SK286554B6 (no)
TR (1) TR200003442T2 (no)
TW (1) TWI247748B (no)
WO (1) WO1999061476A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774211B1 (en) 1998-05-22 2004-08-10 Abbott Laboratories Peptide antiangiogenic drugs
JP4439120B2 (ja) 1998-10-16 2010-03-24 大塚製薬株式会社 新生血管特異的ペプチド
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
ATE348163T1 (de) 1998-10-23 2007-01-15 Amgen Inc Thrombopoietin substitute
US20020183242A1 (en) * 2001-04-11 2002-12-05 Jack Henkin Peptide antiangiogenic drugs
US20030050246A1 (en) * 2001-07-26 2003-03-13 Fortuna Haviv Peptides having antiangiogenic activity
US20030125259A1 (en) 2001-10-31 2003-07-03 Fortuna Haviv Octa- and nonapeptides having antiangiogenic activity
US7037897B2 (en) 2001-10-31 2006-05-02 Abbott Laboratories TRI-, TETRA-, and penta-peptides having antiangiogenic activity
TWI268934B (en) * 2001-10-31 2006-12-21 Abbott Lab HEPTA-, OCTA- and nonapeptides having antiangiogenic activity
MXPA04004135A (es) * 2001-10-31 2004-07-08 Abbott Lab Tetra-, penta-, hexa y heptapeptidos con actividad antiangiogenica.
US20030105025A1 (en) * 2001-10-31 2003-06-05 Fortuna Haviv Tri-and tetrapeptides having antiangiogenic activity
US7001984B2 (en) 2001-10-31 2006-02-21 Abbott Laboratories Di-, tri-, and tetra-peptides having antiangiogenic activity
US7169888B2 (en) 2001-10-31 2007-01-30 Abbott Laboratories Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
US20030119746A1 (en) * 2001-10-31 2003-06-26 Fortuna Haviv Hepta-and octapeptides having antiangiogenic activity
US7067490B2 (en) 2001-10-31 2006-06-27 Abbott Laboratories Hepta-, Octa-and nonapeptides having antiangiogenic activity
US7122625B2 (en) 2001-10-31 2006-10-17 Abbott Laboratories Hexa-, hepta-, and octapeptides having antiangiogenic activity
US20030125260A1 (en) * 2001-10-31 2003-07-03 Fortuna Haviv Tetra-and pentapeptides having antiangiogenic activity
BR0308654A (pt) 2002-03-22 2005-02-22 Gpc Biotech Ag Compostos imunossupressores, métodos e usos relacionados a eles
US7432245B2 (en) 2002-06-07 2008-10-07 Abbott Laboratories Inc. Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
US20030228365A1 (en) * 2002-06-07 2003-12-11 Fortuna Haviv Pharmaceutical formulation
CA2580796C (en) 2004-09-24 2013-03-26 Amgen Inc. Modified fc molecules having peptides inserted in internal loop regions
JP5167473B2 (ja) 2005-03-03 2013-03-21 コヴェックス・テクノロジーズ・アイルランド・リミテッド 抗血管新生化合物
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
JP2007255910A (ja) * 2006-03-20 2007-10-04 Hokkaido Univ Ｎｍｒシグナルの帰属方法
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
WO2008003013A2 (en) * 2006-06-29 2008-01-03 Abbott Laboratories Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic
CN104004057B (zh) * 2013-02-25 2016-08-24 上海市第一人民医院 一类抑制新生血管的小肽及其应用
CN107778355B (zh) * 2016-08-25 2021-04-20 成都圣诺生物制药有限公司 一种合成西曲瑞克的方法
JP2025001049A (ja) * 2021-09-01 2025-01-08 積水メディカル株式会社 アルギニン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200397A (en) * 1990-02-22 1993-04-06 W. R. Grace & Co.-Conn. Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
WO1993016716A1 (en) * 1992-02-24 1993-09-02 Northwestern University Method and composition for inhibiting angiogenesis
JP4426650B2 (ja) * 1996-05-03 2010-03-03 アボット・ラボラトリーズ 新規な抗血管形成ペプチド、それをコードするポリヌクレオチド、および血管形成を阻害する方法
DK0918795T3 (da) * 1997-03-17 2005-03-14 Abbott Lab Antiangiogene lægemidler til behandling af cancer, arthritis og retinopati

Also Published As

Publication number Publication date
NO326871B1 (no) 2009-03-09
EP1078002B1 (en) 2008-05-21
JP2006001923A (ja) 2006-01-05
CZ20004327A3 (cs) 2001-08-15
BG105064A (en) 2001-08-31
BG65065B1 (bg) 2007-01-31
CY1109118T1 (el) 2014-07-02
TWI247748B (en) 2006-01-21
CA2329250C (en) 2012-03-27
SK17632000A3 (sk) 2001-07-10
EP1078002A1 (en) 2001-02-28
HK1037376A1 (en) 2002-02-08
SI1078002T1 (sl) 2008-10-31
CN1311796A (zh) 2001-09-05
HUP0102579A3 (en) 2002-02-28
NO20005890L (no) 2001-01-12
AR018371A1 (es) 2001-11-14
PL200471B1 (pl) 2009-01-30
JP2002516342A (ja) 2002-06-04
PL344415A1 (en) 2001-11-05
CZ299639B6 (cs) 2008-10-01
ATE396204T1 (de) 2008-06-15
KR100447696B1 (ko) 2004-09-08
CA2329250A1 (en) 1999-12-02
TR200003442T2 (tr) 2001-03-21
SK286554B6 (sk) 2008-12-05
PT1078002E (pt) 2008-09-02
HUP0102579A2 (hu) 2002-01-28
JP3795906B2 (ja) 2006-07-12
DE69938782D1 (de) 2008-07-03
KR20010025093A (ko) 2001-03-26
BR9910639A (pt) 2002-01-15
AU764277B2 (en) 2003-08-14
AU4407599A (en) 1999-12-13
WO1999061476A1 (en) 1999-12-02
JP3753612B2 (ja) 2006-03-08
ES2307337T3 (es) 2008-11-16
JP2006232840A (ja) 2006-09-07
CO5080726A1 (es) 2001-09-25
NZ507912A (en) 2002-10-25

Similar Documents

Publication Publication Date Title
NO20005890L (no) Antiangiogene peptidmedikamenter
NO20001776D0 (no) Medikamenter
NO982097L (no) Peptider
NO982098D0 (no) Peptider
NO20004773D0 (no) Forlenget-frigjøringsblandinger
ID26334A (id) Morfolinol yang aktif secara farmasi
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
DK1040051T3 (da) Blisterpakning
DE69820407D1 (de) Blisterpackung
ID27841A (id) Turunan-turunan biaril terapeutik
NO980546D0 (no) Farmasöytiske midler
ID29089A (id) Sediaan farmasi moksifloksasin
DK1466615T3 (da) Farmaceutisk præparat
DK1017392T3 (da) Lægemiddel
DE69915660D1 (de) Blisterverpackung
ID27150A (id) Sediaan levotiroksin bahan farmasi
DE69926012D1 (de) Arzneizubereitungen
NO994619L (no) Farmasöytiske blandinger
NO20003141D0 (no) Farmasøytiske blandinger
FR2782671B3 (fr) Livre
EP1159288A4 (en) ALPHA-CONOTOXIN PEPTIDES
DE69906934D1 (de) Arzneizubereitungen
EP1151100A4 (en) TAU-CONOTOXIN PEPTIDE
SE9801216D0 (sv) Pharmaceuticals
IL139434A0 (en) Peptide antiangiogenic drugs

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees